Waters Corporation and Quest Diagnostics Help Close Cervical Cancer Screening Gap Bringing Nationwide Access to the Most Comprehensive FDA-Cleared At-Home HPV Screening Option
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Quest Diagnostics (NYSE: DGX) | Delayed: 242.12 -1.16 (0.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $243.28 | 52 Week High | $86.85 | |||
| Open | $239.63 | 52 Week Low | $59.66 | |||
| Day High | $243.90 | P/E | 45.60 | |||
| Day Low | $239.63 | EPS | $5.31 | |||
| Volume | 111,443 | |||||
| Waters Corporation (NYSE: WAT) | Delayed: 453.18 -2.41 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $455.59 | 52 Week High | $162.53 | |||
| Open | $458.16 | 52 Week Low | $112.00 | |||
| Day High | $458.16 | P/E | 87.15 | |||
| Day Low | $446.70 | EPS | $5.20 | |||
| Volume | 166,804 | |||||
